Tag: APIs

  • Shilpa Medicare Shares Surge Following CEP Approval for Desmopressin

    Shilpa Medicare's shares surged following the company's announcement of receiving a Certificate of Suitability (CEP) from the EDQM for Desmopressin, a key active pharmaceutical ingredient. This approval not only highlights Shilpa's commitment to quality and innovation but also positions it for future growth in the pharmaceutical market. Explore the implications of this milestone and its potential impact on patients and investors.